{ "data": { "asOf": "2026-10-30T22:24:36.889Z", "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "byRegistry": { "clinicaltrials_gov": 1 }, "canonicalTrial": { "canonicalId": "NCT07709494", "title": "A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa", "scientificTitle": "A Sequential, Phase 1a/1b, Double-blind, 2-part Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Rev-56 for Inhalation Compared With Placebo in Healthy Adult Participants and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic Pseudomonas Aeruginosa", "status": "active", "studyType": "interventional", "phase": [ "PHASE1" ], "conditions": [ "Healthy Participants", "Non-cystic Fibrosis Bronchiectasis" ], "interventions": [ { "name": "Rev-56 for Inhalation", "type": "COMBINATION_PRODUCT", "description": "administered by inhalation via an investigational nebulizer device" }, { "name": "Placebo: Normal saline", "type": "DRUG", "description": "administered by inhalation via an investigational nebulizer device" } ], "sponsor": { "name": "Revagenix, Inc.", "type": "INDUSTRY" }, "locations": [ { "city": "Miami", "country": "United States", "facility": "Syneos Health Miami" } ], "outcomes": { "other": [], "primary": [ "Incidence and severity of treatment-emergent adverse events (AEs)", "Number of participants with clinically significant abnormalities in lab parameters, vital signs, respiratory function, and ECG parameters graded by FDA Toxicity Grading Scale (for healthy participants) and DAIDS Toxicity Tables (for NCFB patients)" ], "secondary": [ "Maximum observed concentration (Cmax) of Rev-56", "Time to Cmax of Rev-56 (Tmax)", "Area under the curve from time 0 to last measurable concentration (AUC0-last)", "Area under the curve from time 0 to 24 hours after completion of dosing (AUC0-24)", "Area under the curve from time 0 to infinity (AUC0-inf)", "Clearance of Rev-56 (CL/F)", "Half-life of Rev-56 (t½)", "Volume of distribution of Rev-56 (Vz/F)", "Minimum observed concentration of Rev-56 (Cmin)", "Mean P. aeruginosa burden (CFU/mL) in sputum culture compared to baseline" ] }, "eligibility": { "sex": "ALL", "criteria": "Inclusion Criteria (Healthy Participants):\n\n* Healthy male and female participants aged 18 to 55 years, inclusive\n* Body mass index \\> 18 to ≤ 32 kg/m\\^2\n* Forced expiratory volume in 1 second (FEV1) ≥ 80%\n* Creatinine clearance ≥ 90 mL/min\n* Normal laboratory values and physical exam at screening, or Grade 1 abnormalities that are not clinically significant\n\nInclusion Criteria (NCFB Patients with P. aeruginosa):\n\n* Male and female NCFB patients aged 18 to 80 years, inclusive\n* Bronchiectasis confirmed by prior computerized tomography (CT) scan\n* Chronic P. aeruginosa infection (≥ 2 positive cultures within prior 12 months)\n* Screening sputum culture positive for P. aeruginosa at ≥ 10\\^4 CFU/mL\n* FEV1 ≥ 50% (post bronchodilator)\n\nExclusion Criteria (Healthy Participants):\n\n* Clinically significant medical history\n* Acute illness within 4 weeks of screening\n* Current smoker or nicotine user\n* History of alcohol abuse (within prior 12 months) or drug/chemical abuse\n\nExclusion Criteria (NCFB Patients with P. aeruginosa):\n\n* Primary asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis (CF)\n* More than 2 pulmonary exacerbations requiring IV antibiotics within 12 months prior to screening\n* Receipt of antibiotics (excluding macrolides) within 30 days prior to screening\n* Clinically significant hemoptysis requiring intervention within 30 days prior to screening\n* Receiving anti-infective treatment for concurrent nontuberculosis mycobacteria (NTM) or fungal infection", "maximumAge": "80 Years", "minimumAge": "18 Years", "healthyVolunteers": true }, "enrollment": { "type": "ESTIMATED", "count": 64 }, "startDate": "2026-07-13", "completionDate": "2027-07-01", "lastUpdated": "2026-10-14T00:00:00.000Z", "firstPosted": "2026-07-16T00:00:00.000Z", "resultsAvailable": false, "sourceRegistries": [ "clinicaltrials_gov" ], "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07709494" ] }, "identifiers": [ { "idType": "nct", "idValue": "NCT07709494", "declaredBy": "clinicaltrials_gov" } ], "sourceRecords": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07709494", "sourceUrl": "https://clinicaltrials.gov/study/NCT07709494", "sourceStatus": "ACTIVE_NOT_RECRUITING", "retrievedAt": "2026-10-28T04:32:26.461Z", "payloadSha256": "1b78fd7b1ace62f3cd23cc6ec82b4727347ff9750079bda859996c0fd1fc7274", "piiRedacted": true } ], "citation": { "canonicalId": "NCT07709494", "sources": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07709494", "verifyAt": "https://clinicaltrials.gov/study/NCT07709494", "retrievedAt": "2026-10-28T04:32:26.461Z", "payloadSha256": "1b78fd7b1ace62f3cd23cc6ec82b4727347ff9750079bda859996c0fd1fc7274", "text": "ClinicalTrials.gov, record NCT07709494 (https://clinicaltrials.gov/study/NCT07709494), retrieved 2026-10-28, licence: public-domain." } ], "crossRegistry": false, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "text": "Trial NCT07709494, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.", "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there." }, "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served." }, "_meta": { "api": "The Last Economy Wire: World Trials API", "version": "1.0", "schemaVersion": "1", "correlationId": "req_Mfy8rxrGHkkE", "generatedAt": "2026-10-30T22:24:36.889Z", "documentation": "https://negativeresistance.com/embed", "license": "Free for any use. Attribution appreciated.", "degraded": false, "provenance": { "sources": [ "clinicaltrials_gov" ], "attribution": { "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs" }, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "limitations": [], "provenanceEndpoint": "/api/v1/sources" }, "freshness": { "newestEvidenceAt": null, "lastSyncedAt": { "clinicaltrials_gov": "2026-10-28T04:33:30.663Z" }, "degradedSources": [], "worldwide": false, "maxAgeHours": 65.9, "fromCache": false }, "links": { "discovery": "https://negativeresistance.com/api/v1", "openapi": "https://negativeresistance.com/api/v1/openapi.json", "mcp": "https://negativeresistance.com/api/v1/mcp", "agentCard": "https://negativeresistance.com/.well-known/agent.json", "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json", "sdk": "https://negativeresistance.com/api/v1/sdk", "status": "https://negativeresistance.com/api/v1/status", "provenance": "https://negativeresistance.com/api/v1/sources", "contract": "https://negativeresistance.com/api/v1/contract", "curriculum": "https://negativeresistance.com/api/v1/curriculum", "graph": "https://negativeresistance.com/api/v1/graph", "openQuestions": "https://negativeresistance.com/api/v1/open-questions", "scoreboard": "https://negativeresistance.com/api/v1/scoreboard", "findings": "https://negativeresistance.com/api/v1/findings", "claims": "https://negativeresistance.com/api/v1/claims", "threads": "https://negativeresistance.com/api/v1/threads", "assignment": "https://negativeresistance.com/api/v1/assignment", "changes": "https://negativeresistance.com/api/v1/changes", "hello": "https://negativeresistance.com/api/v1/hello", "errors": "https://negativeresistance.com/api/v1/errors", "webhooks": "https://negativeresistance.com/api/v1/webhooks", "a2a": "https://negativeresistance.com/api/v1/a2a", "deadEnds": "https://negativeresistance.com/api/v1/dead-ends", "decompositions": "https://negativeresistance.com/api/v1/decompositions", "rungs": "https://negativeresistance.com/api/v1/rungs", "methods": "https://negativeresistance.com/api/v1/methods", "reality": "https://negativeresistance.com/api/v1/reality", "council": "https://negativeresistance.com/api/v1/council", "calibration": "https://negativeresistance.com/api/v1/calibration", "freshness": "https://negativeresistance.com/api/v1/freshness", "mission": "https://negativeresistance.com/api/v1/mission", "twin": "https://negativeresistance.com/api/v1/twin", "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment", "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell", "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model", "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json", "collaborate": "https://negativeresistance.com/collaborate", "manifesto": "https://negativeresistance.com/about", "documentation": "https://negativeresistance.com/embed", "connect": "https://negativeresistance.com/connect", "llmsTxt": "https://negativeresistance.com/llms.txt", "llmsFullTxt": "https://negativeresistance.com/llms-full.txt" }, "disclaimer": "Research data from public registries and literature; not medical advice." } }